OncoHost — raw details

Highlights

IIA supported (ever)1 patentProfile claimed by owner

About

Precision Diagnostics and Predictive Biomarker Development

OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes. The company aims to understand the patient's unique response to therapy to overcome one of the major obstacles in clinical oncology today – resistance to treatment.

OncoHost developed the PROphet platform. Combining bioinformatics, system biology, proteomic pattern recognition and machine learning, PROphet provides clinicians with actionable clinical insights, optimal choice of therapy, and a better understanding of their patients' personalized cancer dynamics.

Identity

Name	OncoHost
Slug	oncohost
Type / kind	startup
Crunchbase ID	oncohost
Source _id	agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNXc5pgKDA

Status

Status	active
Last update	2026-05-17

Location

HQ country code	IL
HQ region/district	Center District
HQ city	Binyamina-Giv'at Ada
HQ address	HaMelacha St 17, Binyamina-Giv'at Ada, Israel

Web & social

Website	https://www.oncohost.com
Careers page	https://www.oncohost.com/careers
LinkedIn	https://www.linkedin.com/company/18360929
Twitter / X	https://twitter.com/oncohost?lang=en
Facebook	https://www.facebook.com/OncoHost

Classifications

Primary sector Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesDigital HealthcareMedical Decision SupportPharma & Medical BiotechnologyTest Diagnostics & Screening

Technologies

BiologicalsMoleculesArtificial IntelligenceMachine Learning

Target customers

Healthcare & Life SciencesHealthcareInsurance CompaniesProvidersPatientsLife SciencesPharmaceuticals

Business models

B2B2CB2BB2C

Funding

Total raised	$53.4M
Current stage	Series C

Raw source document

Show full JSON (0 KB)

{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}